Home › Funds › OGOREK ANTHONY JOSEPH /NY/ /ADV › DOCT

OGOREK ANTHONY JOSEPH /NY/ /ADV position in DOCT

FIRST TR EXCHNG TRADED FD VI

OGOREK ANTHONY JOSEPH /NY/ /ADV reported holding 283,355 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 3.38% of its reported portfolio and ranking #9 among its reported holdings. OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)283.36K sh
Reported value held$13.61M
Portfolio Weight3.38%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How OGOREK ANTHONY JOSEPH /NY/ /ADV's DOCT position evolved

OGOREK ANTHONY JOSEPH /NY/ /ADV first disclosed a stake in DOCT in Q4 2024 at 3,553 shares (US$139K). The position peaked in Q3 2026 at 283,355 shares, worth US$13.6M. Across 8 filings, OGOREK ANTHONY JOSEPH /NY/ /ADV increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 283,355 shares valued at US$13.6M. Notable position changes include a 8625% increase in Q1 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 3.55K $139.00K New
Q1 2025 309.98K $11.89M Add
Q2 2025 307.09K $12.61M Reduce
Q3 2025 303.52K $13.11M Reduce
Q4 2025 301.24K $13.34M Reduce
Q1 2026 286.18K $12.43M Reduce
Q2 2026 284.39K $13.28M Reduce
Q3 2026 283.36K $13.61M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DOCT and 13F data

DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in DOCT — the largest reported positions include REAP Financial Group, LLC (US$9.8M), Wood Tarver Financial Group, LLC (US$8.3M), Per Stirling Capital Management, LLC. (US$6.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DOCT

All DOCT fund holders →

FAQ

How long has OGOREK ANTHONY JOSEPH /NY/ /ADV held DOCT?

OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is OGOREK ANTHONY JOSEPH /NY/ /ADV's current position in DOCT?

As of Q3 2026, OGOREK ANTHONY JOSEPH /NY/ /ADV holds 283.36K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $13.61M, representing 3.38% of its reported portfolio and ranking #9.

Has OGOREK ANTHONY JOSEPH /NY/ /ADV been buying or selling DOCT?

In the latest 13F filing (Q3 2026), OGOREK ANTHONY JOSEPH /NY/ /ADV held unchanged its position in DOCT. The position peaked in Q3 2026 at 283.36K shares.

Which other funds hold DOCT?

Other major institutional holders of DOCT include REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, Per Stirling Capital Management, LLC., among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.